$36.62
-1.61-4.21%
Last update: Nov 5, 6:51 PM
Roivant Sciences Ltd (ROIV) Stock Price, Quote, News & History
ROIVNASDAQ
Roivant (ROIV) shares jump as Phase 3 CLARITY trials show brepocitinib effectively treats noninfectious uveitis & reduces steroid reliance.
You can purchase shares of Roivant Sciences (NASDAQ:ROIV) through any online brokerage.
Other companies in Roivant Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Roivant Sciences has a consensus price target of $36.32.
The stock price for Roivant Sciences (NASDAQ: ROIV) is $36.9148 last updated November 5, 2026 at 6:51 PM EST.
There are no upcoming dividends for Roivant Sciences.
Roivant Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Roivant Sciences.
Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical...
